Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | 24434.31 | nM | 18656367 | |
NPT2 | Others | Unspecified | Potency | 20596.2 | nM | 24033101 | ||
NPT2 | Others | Unspecified | Potency | = | 20596.2 | nM | 10.3390/molecules16075618 | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | 24945.95 | nM | 11520240 | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 14581 | nM | 18603337 | |
NPT396 | Cell Line | T47D | Homo sapiens | GI50 | 2857.59 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 10000 | nM | 11902656 | ||
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | 17378.01 | nM | Open TG-GATES in vivo data: Hematology | |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | 19860.95 | nM | 25499431 | |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | 26485 | nM | 10924160 | |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | 25003.45 | nM | PubChem BioAssay data set | |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 26242.19 | nM | 16472241 | |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | 22029.26 | nM | 24709561 | |
NPT160 | Individual Protein | TAR DNA-binding protein 43 | Homo sapiens | Potency | 35481.3 | nM | 15781124 | |
NPT1635 | Cell Line | H9c2 | Rattus norvegicus | IC50 | > | 79000 | nM | DrugMatrix in vitro pharmacology data |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | 21777.1 | nM | PubChem BioAssay data set | |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 23109.3 | nM | 25760525 | |
NPT2 | Others | Unspecified | IC50 | = | 10000 | nM | 25316316 | |
NPT2 | Others | Unspecified | Potency | 8912.5 | nM | 23999046 | ||
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 20796.97 | nM | 19700322 | |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | 19408.86 | nM | 218014 | |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 63386.97 | nM | 25052206 | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | 25763.21 | nM | 2095372 | |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | 25409.73 | nM | 7473578 | |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | 15100.8 | nM | 8021914 | |
NPT2 | Others | Unspecified | IC50 | = | 12100 | nM | 20022253 | |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | 32062.69 | nM | 10425118 | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 165.1 | nM | 20553004 | |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | 11015.39 | nM | 25981688 | |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | 4688.13 | nM | 20411974 | |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | 32210.69 | nM | 17850214 | |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | 1663.41 | nM | 25211145 | |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | 46238.1 | nM | 18936192 | |
NPT457 | Cell Line | BT-549 | Homo sapiens | GI50 | 34434.99 | nM | 19223646 | |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 11220.2 | nM | 19451298 |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | 6807.69 | nM | 19506060 | |
NPT105 | Individual Protein | Muscleblind-like protein 1 | Homo sapiens | Potency | 19952.6 | nM | 18625769 | |
NPT518 | Protein Complex | Tubulin | Homo sapiens | Inhibition | = | 4 | % | 10.1007/s00044-011-9693-2 |
NPT517 | Cell Line | Panel NCI-60 (60 carcinoma cell lines) | Homo sapiens | GI50 | = | 7100 | nM | 10.1007/s00044-012-0292-7 |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | GI50 | 13273.94 | nM | 10514320 | |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | 7870.46 | nM | 10.6019/CHEMBL1201861 | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | 9705.1 | nM | 10.6019/CHEMBL1201861 | |
NPT60 | Individual Protein | Lysosomal alpha-glucosidase | Homo sapiens | Potency | = | 39810.7 | nM | 10.6019/CHEMBL1201861 |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | 14288.94 | nM | 3735324 | |
NPT1323 | Individual Protein | Botulinum neurotoxin type A | Clostridium botulinum (strain Hall / ATCC 3502 / NCTC 13319 / Type A) | EC50 | 20000 | nM | 22233864 | |
NPT2 | Others | Unspecified | Potency | 35481.3 | nM | 10395485 | ||
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 3147.75 | nM | Open TG-GATES in vivo data: Hematology | |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | 10592.54 | nM | Open TG-GATES in vivo data: Hematology | |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 28183.8 | nM | Open TG-GATES in vivo data: Hematology |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | 23550.49 | nM | Open TG-GATES in vivo data: Biochemistry | |
NPT402 | Cell Line | Hs-578T | Homo sapiens | GI50 | 3013.01 | nM | DrugMatrix in vivo data: Hematology | |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 9057.33 | nM | 25744190 | |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | 22698.65 | nM | 10.1039/C4MD00325J | |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | 26424.09 | nM | 21489793 | |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 13963.68 | nM | 23398362 | |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | 36224.3 | nM | PubChem BioAssay data set | |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 9332.54 | nM | 16872140 | |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | 243.22 | nM | 20151678 | |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | 40364.54 | nM | 24571273 | |
NPT2 | Others | Unspecified | Potency | 25929 | nM | PubChem BioAssay data set | ||
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | 36224.3 | nM | 15050646 | |
NPT116 | Cell Line | HL-60 | Homo sapiens | IC50 | = | 4160 | nM | 16033274 |
NPT2 | Others | Unspecified | IC50 | > | 79000 | nM | 16524728 | |
NPT367 | Cell Line | MDA-N | Homo sapiens | GI50 | 10280.16 | nM | 19651905 | |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | 46773.51 | nM | 24411478 | |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | 17988.71 | nM | 27212070 | |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | 3971.92 | nM | 22506638 | |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | 20653.8 | nM | 22472691 | |
NPT2 | Others | Unspecified | Potency | 28183.8 | nM | 1517742 | ||
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 25409.73 | nM | 21683602 | |
NPT91 | Cell Line | KB | Homo sapiens | IC50 | = | 6 | ug/ml | 18808182 |
NPT101 | Individual Protein | Glucagon-like peptide 1 receptor | Homo sapiens | Potency | 2818.4 | nM | 20970332 | |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 27478.94 | nM | 20970332 | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 3294.4 | nM | 10.1007/s00044-013-0779-x | |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | 16710.91 | nM | DrugMatrix in vivo data: Hematology | |
NPT2 | Others | Unspecified | Potency | 11220.2 | nM | 16499313 | ||
NPT135 | Individual Protein | Chromobox protein homolog 1 | Homo sapiens | Potency | 17782.8 | nM | 8627602 | |
NPT150 | Individual Protein | Anthrax lethal factor | Bacillus anthracis | EC50 | 20000 | nM | 23822611 | |
NPT2 | Others | Unspecified | IC50 | > | 79000 | nM | PubChem BioAssay data set | |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 15452.54 | nM | 25581396 | |
NPT116 | Cell Line | HL-60 | Homo sapiens | AC50 | = | 5900 | nM | 1336040 |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | 19319.68 | nM | 16933872 | |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 25118.9 | nM | 22037378 |
NPT755 | Individual Protein | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens | Potency | 79432.8 | nM | 22194678 | |
NPT6277 | Individual Protein | Botulinum neurotoxin type F | Clostridium botulinum | EC50 | 20000 | nM | 10.6019/CHEMBL1201861 | |
NPT518 | Protein Complex | Tubulin | Homo sapiens | IC50 | > | 40000 | nM | 21513293 |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 11577.4 | nM | 19845338 | |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | 35563.13 | nM | 7807120 | |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | GI50 | 22233.1 | nM | 17228858 | |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | 19453.6 | nM | DrugMatrix in vitro pharmacology data | |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 16943.38 | nM | PubChem BioAssay data set | |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | 27733.2 | nM | 19332671 | |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | 37583.74 | nM | 22705001 | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 17782.79 | nM | 6539809 | |
NPT65 | Cell Line | HepG2 | Homo sapiens | Potency | 22387.2 | nM | 15943472 | |
NPT48 | Individual Protein | Lysine-specific demethylase 4D-like | Homo sapiens | Potency | = | 35481.3 | nM | 25019388 |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | 31117.16 | nM | 22584254 | |
NPT2 | Others | Unspecified | Potency | 15848.9 | nM | 2292684 | ||
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | 8203.52 | nM | 10.1016/S0960-894X(01)80881-7 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC7846 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC253634 |
1.0 | High Similarity | NPC19687 |
1.0 | High Similarity | NPC288669 |
1.0 | High Similarity | NPC152166 |
1.0 | High Similarity | NPC143828 |
1.0 | High Similarity | NPC191459 |
1.0 | High Similarity | NPC18607 |
1.0 | High Similarity | NPC115798 |
1.0 | High Similarity | NPC9609 |
1.0 | High Similarity | NPC18772 |
1.0 | High Similarity | NPC130894 |
1.0 | High Similarity | NPC300943 |
1.0 | High Similarity | NPC4481 |
1.0 | High Similarity | NPC105242 |
1.0 | High Similarity | NPC176300 |
1.0 | High Similarity | NPC22472 |
1.0 | High Similarity | NPC261004 |
1.0 | High Similarity | NPC204854 |
1.0 | High Similarity | NPC25495 |
0.9933 | High Similarity | NPC101830 |
0.9933 | High Similarity | NPC176665 |
0.9933 | High Similarity | NPC189179 |
0.9933 | High Similarity | NPC7973 |
0.9933 | High Similarity | NPC227192 |
0.9933 | High Similarity | NPC78302 |
0.9933 | High Similarity | NPC163524 |
0.9933 | High Similarity | NPC93376 |
0.9933 | High Similarity | NPC203891 |
0.9933 | High Similarity | NPC29841 |
0.9933 | High Similarity | NPC235215 |
0.9933 | High Similarity | NPC472438 |
0.9933 | High Similarity | NPC110070 |
0.9933 | High Similarity | NPC224137 |
0.9933 | High Similarity | NPC287979 |
0.9933 | High Similarity | NPC305663 |
0.9933 | High Similarity | NPC75215 |
0.9868 | High Similarity | NPC193842 |
0.9867 | High Similarity | NPC43243 |
0.9867 | High Similarity | NPC55619 |
0.9867 | High Similarity | NPC200388 |
0.9867 | High Similarity | NPC100916 |
0.9867 | High Similarity | NPC474520 |
0.9867 | High Similarity | NPC247017 |
0.9867 | High Similarity | NPC268161 |
0.9867 | High Similarity | NPC178854 |
0.9867 | High Similarity | NPC266960 |
0.9867 | High Similarity | NPC49824 |
0.9867 | High Similarity | NPC245546 |
0.9867 | High Similarity | NPC292107 |
0.9867 | High Similarity | NPC98661 |
0.98 | High Similarity | NPC214138 |
0.98 | High Similarity | NPC196439 |
0.98 | High Similarity | NPC50715 |
0.98 | High Similarity | NPC32557 |
0.98 | High Similarity | NPC189960 |
0.98 | High Similarity | NPC167815 |
0.98 | High Similarity | NPC92659 |
0.98 | High Similarity | NPC4455 |
0.98 | High Similarity | NPC2476 |
0.98 | High Similarity | NPC44079 |
0.98 | High Similarity | NPC280339 |
0.98 | High Similarity | NPC201136 |
0.98 | High Similarity | NPC138360 |
0.98 | High Similarity | NPC163780 |
0.98 | High Similarity | NPC26227 |
0.98 | High Similarity | NPC128863 |
0.98 | High Similarity | NPC201451 |
0.98 | High Similarity | NPC183597 |
0.98 | High Similarity | NPC146165 |
0.98 | High Similarity | NPC227325 |
0.9735 | High Similarity | NPC265511 |
0.9733 | High Similarity | NPC276409 |
0.9733 | High Similarity | NPC86485 |
0.9733 | High Similarity | NPC250822 |
0.9733 | High Similarity | NPC69394 |
0.9733 | High Similarity | NPC162351 |
0.9733 | High Similarity | NPC270620 |
0.9733 | High Similarity | NPC78326 |
0.9733 | High Similarity | NPC75279 |
0.9733 | High Similarity | NPC183878 |
0.9733 | High Similarity | NPC160951 |
0.9733 | High Similarity | NPC22519 |
0.9733 | High Similarity | NPC246204 |
0.9733 | High Similarity | NPC231018 |
0.9733 | High Similarity | NPC179126 |
0.9733 | High Similarity | NPC274327 |
0.9733 | High Similarity | NPC145379 |
0.9733 | High Similarity | NPC236223 |
0.9733 | High Similarity | NPC58382 |
0.9733 | High Similarity | NPC176775 |
0.9733 | High Similarity | NPC255350 |
0.9733 | High Similarity | NPC47781 |
0.9673 | High Similarity | NPC246478 |
0.9669 | High Similarity | NPC256612 |
0.9669 | High Similarity | NPC20830 |
0.9669 | High Similarity | NPC208197 |
0.9669 | High Similarity | NPC213622 |
0.9667 | High Similarity | NPC57030 |
0.9667 | High Similarity | NPC301123 |
0.9667 | High Similarity | NPC83508 |
0.9667 | High Similarity | NPC275722 |
0.9667 | High Similarity | NPC120163 |
0.9667 | High Similarity | NPC301323 |
0.9667 | High Similarity | NPC82325 |
0.9667 | High Similarity | NPC25270 |
0.9667 | High Similarity | NPC279989 |
0.9667 | High Similarity | NPC156222 |
0.9667 | High Similarity | NPC198826 |
0.9667 | High Similarity | NPC123886 |
0.9667 | High Similarity | NPC27208 |
0.9667 | High Similarity | NPC100887 |
0.9667 | High Similarity | NPC256283 |
0.9667 | High Similarity | NPC222830 |
0.9667 | High Similarity | NPC293183 |
0.9667 | High Similarity | NPC239128 |
0.9667 | High Similarity | NPC187498 |
0.9667 | High Similarity | NPC188203 |
0.9667 | High Similarity | NPC142540 |
0.9667 | High Similarity | NPC241498 |
0.9667 | High Similarity | NPC162313 |
0.9667 | High Similarity | NPC134677 |
0.9667 | High Similarity | NPC275836 |
0.9667 | High Similarity | NPC131624 |
0.9667 | High Similarity | NPC212678 |
0.9667 | High Similarity | NPC71334 |
0.9613 | High Similarity | NPC470459 |
0.9608 | High Similarity | NPC195832 |
0.96 | High Similarity | NPC76376 |
0.96 | High Similarity | NPC208043 |
0.96 | High Similarity | NPC252933 |
0.96 | High Similarity | NPC226973 |
0.96 | High Similarity | NPC133953 |
0.96 | High Similarity | NPC225731 |
0.96 | High Similarity | NPC50403 |
0.96 | High Similarity | NPC125062 |
0.96 | High Similarity | NPC236769 |
0.96 | High Similarity | NPC28274 |
0.96 | High Similarity | NPC200740 |
0.96 | High Similarity | NPC54394 |
0.9554 | High Similarity | NPC76482 |
0.9551 | High Similarity | NPC470457 |
0.9542 | High Similarity | NPC470402 |
0.9536 | High Similarity | NPC55205 |
0.9536 | High Similarity | NPC39732 |
0.9536 | High Similarity | NPC60972 |
0.9533 | High Similarity | NPC201547 |
0.9533 | High Similarity | NPC77858 |
0.9533 | High Similarity | NPC219330 |
0.9533 | High Similarity | NPC188871 |
0.9533 | High Similarity | NPC50728 |
0.9533 | High Similarity | NPC166753 |
0.9533 | High Similarity | NPC286342 |
0.9533 | High Similarity | NPC259058 |
0.9533 | High Similarity | NPC306821 |
0.9533 | High Similarity | NPC184136 |
0.9533 | High Similarity | NPC149127 |
0.9494 | High Similarity | NPC280493 |
0.949 | High Similarity | NPC470462 |
0.9481 | High Similarity | NPC152904 |
0.9477 | High Similarity | NPC472916 |
0.947 | High Similarity | NPC260895 |
0.947 | High Similarity | NPC308451 |
0.9467 | High Similarity | NPC328119 |
0.9467 | High Similarity | NPC52005 |
0.9467 | High Similarity | NPC48479 |
0.9467 | High Similarity | NPC181250 |
0.9467 | High Similarity | NPC177298 |
0.9467 | High Similarity | NPC216318 |
0.9467 | High Similarity | NPC259713 |
0.9467 | High Similarity | NPC69752 |
0.9467 | High Similarity | NPC183950 |
0.9467 | High Similarity | NPC195351 |
0.9467 | High Similarity | NPC87125 |
0.9467 | High Similarity | NPC17286 |
0.9467 | High Similarity | NPC270465 |
0.9467 | High Similarity | NPC137062 |
0.9467 | High Similarity | NPC159103 |
0.9467 | High Similarity | NPC223579 |
0.9467 | High Similarity | NPC296197 |
0.9467 | High Similarity | NPC287101 |
0.943 | High Similarity | NPC295082 |
0.943 | High Similarity | NPC158761 |
0.943 | High Similarity | NPC470456 |
0.9419 | High Similarity | NPC263449 |
0.9419 | High Similarity | NPC476980 |
0.9416 | High Similarity | NPC471479 |
0.9416 | High Similarity | NPC78225 |
0.9416 | High Similarity | NPC474836 |
0.9416 | High Similarity | NPC472910 |
0.9416 | High Similarity | NPC471515 |
0.9416 | High Similarity | NPC222814 |
0.9416 | High Similarity | NPC174908 |
0.9416 | High Similarity | NPC472913 |
0.9416 | High Similarity | NPC48208 |
0.9416 | High Similarity | NPC472914 |
0.9416 | High Similarity | NPC96167 |
0.9416 | High Similarity | NPC156057 |
0.9416 | High Similarity | NPC162869 |
0.9416 | High Similarity | NPC472911 |
0.9416 | High Similarity | NPC245758 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC7846 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9733 | High Similarity | NPD2801 | Approved |
0.9351 | High Similarity | NPD3882 | Suspended |
0.9286 | High Similarity | NPD3817 | Phase 2 |
0.9267 | High Similarity | NPD1512 | Approved |
0.9156 | High Similarity | NPD1934 | Approved |
0.9141 | High Similarity | NPD4338 | Clinical (unspecified phase) |
0.9133 | High Similarity | NPD1511 | Approved |
0.9062 | High Similarity | NPD6166 | Phase 2 |
0.9062 | High Similarity | NPD6168 | Clinical (unspecified phase) |
0.9062 | High Similarity | NPD6167 | Clinical (unspecified phase) |
0.8974 | High Similarity | NPD2393 | Clinical (unspecified phase) |
0.8902 | High Similarity | NPD6797 | Phase 2 |
0.8848 | High Similarity | NPD7251 | Discontinued |
0.8834 | High Similarity | NPD3818 | Discontinued |
0.8824 | High Similarity | NPD4378 | Clinical (unspecified phase) |
0.8795 | High Similarity | NPD7808 | Phase 3 |
0.878 | High Similarity | NPD7054 | Approved |
0.8727 | High Similarity | NPD7472 | Approved |
0.8679 | High Similarity | NPD5402 | Approved |
0.8614 | High Similarity | NPD7074 | Phase 3 |
0.8571 | High Similarity | NPD7075 | Discontinued |
0.8516 | High Similarity | NPD6799 | Approved |
0.8509 | High Similarity | NPD4868 | Clinical (unspecified phase) |
0.8466 | Intermediate Similarity | NPD5494 | Approved |
0.8438 | Intermediate Similarity | NPD6801 | Discontinued |
0.8428 | Intermediate Similarity | NPD4380 | Phase 2 |
0.8415 | Intermediate Similarity | NPD1247 | Approved |
0.8385 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.8364 | Intermediate Similarity | NPD6232 | Discontinued |
0.8344 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.8333 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.8323 | Intermediate Similarity | NPD7473 | Discontinued |
0.8247 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.8247 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.8239 | Intermediate Similarity | NPD5403 | Approved |
0.8235 | Intermediate Similarity | NPD1510 | Phase 2 |
0.8235 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.8228 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.8204 | Intermediate Similarity | NPD3926 | Phase 2 |
0.8199 | Intermediate Similarity | NPD6599 | Discontinued |
0.8194 | Intermediate Similarity | NPD1549 | Phase 2 |
0.8182 | Intermediate Similarity | NPD2796 | Approved |
0.816 | Intermediate Similarity | NPD1465 | Phase 2 |
0.8113 | Intermediate Similarity | NPD5401 | Approved |
0.8092 | Intermediate Similarity | NPD943 | Approved |
0.8092 | Intermediate Similarity | NPD1240 | Approved |
0.8072 | Intermediate Similarity | NPD919 | Approved |
0.8049 | Intermediate Similarity | NPD7819 | Suspended |
0.8012 | Intermediate Similarity | NPD5844 | Phase 1 |
0.8 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.7987 | Intermediate Similarity | NPD1607 | Approved |
0.7962 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.7927 | Intermediate Similarity | NPD7411 | Suspended |
0.7925 | Intermediate Similarity | NPD6190 | Approved |
0.7885 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.787 | Intermediate Similarity | NPD6959 | Discontinued |
0.7834 | Intermediate Similarity | NPD2935 | Discontinued |
0.7829 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7806 | Intermediate Similarity | NPD230 | Phase 1 |
0.7806 | Intermediate Similarity | NPD447 | Suspended |
0.7791 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7778 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7771 | Intermediate Similarity | NPD6559 | Discontinued |
0.7763 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.775 | Intermediate Similarity | NPD3750 | Approved |
0.7746 | Intermediate Similarity | NPD3751 | Discontinued |
0.7744 | Intermediate Similarity | NPD1653 | Approved |
0.7742 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7742 | Intermediate Similarity | NPD1613 | Approved |
0.7719 | Intermediate Similarity | NPD3787 | Discontinued |
0.7688 | Intermediate Similarity | NPD2800 | Approved |
0.768 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.7667 | Intermediate Similarity | NPD8397 | Clinical (unspecified phase) |
0.7662 | Intermediate Similarity | NPD3027 | Phase 3 |
0.763 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.7613 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.761 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7598 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.7588 | Intermediate Similarity | NPD3749 | Approved |
0.7561 | Intermediate Similarity | NPD2534 | Approved |
0.7561 | Intermediate Similarity | NPD2532 | Approved |
0.7561 | Intermediate Similarity | NPD2533 | Approved |
0.7558 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7544 | Intermediate Similarity | NPD6234 | Discontinued |
0.7532 | Intermediate Similarity | NPD9494 | Approved |
0.7531 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.7529 | Intermediate Similarity | NPD7768 | Phase 2 |
0.75 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7487 | Intermediate Similarity | NPD7501 | Clinical (unspecified phase) |
0.7485 | Intermediate Similarity | NPD3226 | Approved |
0.747 | Intermediate Similarity | NPD920 | Approved |
0.7469 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7468 | Intermediate Similarity | NPD1933 | Approved |
0.7453 | Intermediate Similarity | NPD2344 | Approved |
0.7452 | Intermediate Similarity | NPD6233 | Phase 2 |
0.7438 | Intermediate Similarity | NPD3748 | Approved |
0.7423 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7421 | Intermediate Similarity | NPD6651 | Approved |
0.7419 | Intermediate Similarity | NPD8090 | Clinical (unspecified phase) |
0.7416 | Intermediate Similarity | NPD5953 | Discontinued |
0.7391 | Intermediate Similarity | NPD6100 | Approved |
0.7391 | Intermediate Similarity | NPD6099 | Approved |
0.7389 | Intermediate Similarity | NPD2313 | Discontinued |
0.7374 | Intermediate Similarity | NPD7685 | Pre-registration |
0.7363 | Intermediate Similarity | NPD8434 | Phase 2 |
0.7362 | Intermediate Similarity | NPD1243 | Approved |
0.7353 | Intermediate Similarity | NPD37 | Approved |
0.7349 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7333 | Intermediate Similarity | NPD4419 | Clinical (unspecified phase) |
0.733 | Intermediate Similarity | NPD2403 | Approved |
0.7329 | Intermediate Similarity | NPD2799 | Discontinued |
0.7329 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.7326 | Intermediate Similarity | NPD4966 | Approved |
0.7326 | Intermediate Similarity | NPD4965 | Approved |
0.7326 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7303 | Intermediate Similarity | NPD7286 | Phase 2 |
0.7302 | Intermediate Similarity | NPD6779 | Approved |
0.7302 | Intermediate Similarity | NPD6782 | Approved |
0.7302 | Intermediate Similarity | NPD6777 | Approved |
0.7302 | Intermediate Similarity | NPD6776 | Approved |
0.7302 | Intermediate Similarity | NPD6780 | Approved |
0.7302 | Intermediate Similarity | NPD6778 | Approved |
0.7302 | Intermediate Similarity | NPD6781 | Approved |
0.729 | Intermediate Similarity | NPD1203 | Approved |
0.7289 | Intermediate Similarity | NPD7390 | Discontinued |
0.7278 | Intermediate Similarity | NPD6798 | Discontinued |
0.7277 | Intermediate Similarity | NPD7435 | Discontinued |
0.7273 | Intermediate Similarity | NPD2309 | Approved |
0.7261 | Intermediate Similarity | NPD6832 | Phase 2 |
0.7251 | Intermediate Similarity | NPD6844 | Discontinued |
0.7247 | Intermediate Similarity | NPD7228 | Approved |
0.7239 | Intermediate Similarity | NPD2346 | Discontinued |
0.7232 | Intermediate Similarity | NPD7784 | Clinical (unspecified phase) |
0.7229 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.7219 | Intermediate Similarity | NPD1548 | Phase 1 |
0.7208 | Intermediate Similarity | NPD9269 | Phase 2 |
0.7197 | Intermediate Similarity | NPD3018 | Phase 2 |
0.7175 | Intermediate Similarity | NPD5242 | Approved |
0.7174 | Intermediate Similarity | NPD8150 | Discontinued |
0.717 | Intermediate Similarity | NPD3268 | Approved |
0.7152 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7143 | Intermediate Similarity | NPD7422 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD6355 | Discontinued |
0.7143 | Intermediate Similarity | NPD422 | Phase 1 |
0.7134 | Intermediate Similarity | NPD2798 | Approved |
0.7117 | Intermediate Similarity | NPD7033 | Discontinued |
0.7108 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7104 | Intermediate Similarity | NPD8313 | Approved |
0.7104 | Intermediate Similarity | NPD8312 | Approved |
0.7098 | Intermediate Similarity | NPD7697 | Approved |
0.7098 | Intermediate Similarity | NPD7698 | Approved |
0.7098 | Intermediate Similarity | NPD7696 | Phase 3 |
0.7097 | Intermediate Similarity | NPD9717 | Approved |
0.7093 | Intermediate Similarity | NPD6385 | Approved |
0.7093 | Intermediate Similarity | NPD6386 | Approved |
0.7083 | Intermediate Similarity | NPD4357 | Discontinued |
0.7081 | Intermediate Similarity | NPD4060 | Phase 1 |
0.707 | Intermediate Similarity | NPD2797 | Approved |
0.7069 | Intermediate Similarity | NPD5353 | Approved |
0.7066 | Intermediate Similarity | NPD2354 | Approved |
0.7063 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.7062 | Intermediate Similarity | NPD7871 | Phase 2 |
0.7062 | Intermediate Similarity | NPD7870 | Phase 2 |
0.7056 | Intermediate Similarity | NPD7875 | Clinical (unspecified phase) |
0.7056 | Intermediate Similarity | NPD2163 | Approved |
0.7056 | Intermediate Similarity | NPD7874 | Approved |
0.7051 | Intermediate Similarity | NPD2982 | Phase 2 |
0.7051 | Intermediate Similarity | NPD2983 | Phase 2 |
0.7048 | Intermediate Similarity | NPD2654 | Approved |
0.7041 | Intermediate Similarity | NPD7701 | Phase 2 |
0.7039 | Intermediate Similarity | NPD5536 | Phase 2 |
0.7037 | Intermediate Similarity | NPD4363 | Phase 3 |
0.7037 | Intermediate Similarity | NPD4360 | Phase 2 |
0.7037 | Intermediate Similarity | NPD6534 | Approved |
0.7037 | Intermediate Similarity | NPD6535 | Approved |
0.7032 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.7032 | Intermediate Similarity | NPD1610 | Phase 2 |
0.703 | Intermediate Similarity | NPD1471 | Phase 3 |
0.7022 | Intermediate Similarity | NPD5710 | Approved |
0.7022 | Intermediate Similarity | NPD5711 | Approved |
0.7012 | Intermediate Similarity | NPD4308 | Phase 3 |
0.7006 | Intermediate Similarity | NPD3225 | Approved |
0.7 | Intermediate Similarity | NPD7095 | Approved |
0.699 | Remote Similarity | NPD7584 | Approved |
0.6987 | Remote Similarity | NPD1608 | Approved |
0.6987 | Remote Similarity | NPD2981 | Phase 2 |
0.6981 | Remote Similarity | NPD2861 | Phase 2 |
0.6961 | Remote Similarity | NPD7907 | Approved |
0.6957 | Remote Similarity | NPD411 | Approved |
0.6957 | Remote Similarity | NPD7549 | Discontinued |
0.6948 | Remote Similarity | NPD9268 | Approved |
0.6946 | Remote Similarity | NPD2899 | Discontinued |
0.6946 | Remote Similarity | NPD1652 | Phase 2 |
0.6941 | Remote Similarity | NPD3146 | Approved |
0.6941 | Remote Similarity | NPD7004 | Clinical (unspecified phase) |
0.6941 | Remote Similarity | NPD3688 | Clinical (unspecified phase) |
0.6935 | Remote Similarity | NPD7782 | Clinical (unspecified phase) |
0.6935 | Remote Similarity | NPD7801 | Approved |
PubChem CID   | 136417 |
ChEMBL   | CHEMBL422237 |
ZINC   |
Molecular Weight:   | 418.13 |
ALogP:   | -1.6148 |
MLogP:   | 2.78 |
XLogP:   | 1.513 |
# Rotatable Bonds:   | 14 |
Polar Surface Area:   | 101.91 |
# H-Bond Aceptor:   | 2 |
# H-Bond Donor:   | 1 |
# Rings:   | 3 |
# Heavy Atoms:   | 30 |